---
title: TP53 status and impact on AML prognosis within the ELN 2022 risk classification
date: '2023-08-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37647854/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20230831181054&v=2.17.9.post6+86293ac
source: Blood
description: This study reports 1) frequency of TP53 co-mutation within each component
  of the ELN 2022 AML risk classification, 2) relevance of TP53 mut VAF<10%, 3) prognostic
  impact of -7, -5/del(5q), -17/abn(17p), CK/MK or myelodysplasia related gene mutations
  with/without mutated ...
disable_comments: true
---
This study reports 1) frequency of TP53 co-mutation within each component of the ELN 2022 AML risk classification, 2) relevance of TP53 mut VAF<10%, 3) prognostic impact of -7, -5/del(5q), -17/abn(17p), CK/MK or myelodysplasia related gene mutations with/without mutated ...